Meningococcus, an obligate human bacterial pathogen, remains a worldwide and
devastating cause of epidemic meningitis and sepsis. However, advances have been made …

Colonization of the human nasopharyngeal tract by the bacterium Neisseria meningitidis is
usually asymptomatic, but life-threatening meningococcal disease with a clinical …

The human bacterial pathogen Neisseria meningitidis remains a serious worldwide health
threat, but progress is being made toward the control of meningococcal infections. This …

Background Meningococcal disease continues to be a global public health concern due to
its epidemic potential, severity, and sequelae. The global epidemiological data on …

Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA),
MenAfriVac, was first introduced in mass vaccination campaigns of 1–29-year-olds in …

Background Invasive meningococcal disease (IMD), caused by Neisseria meningitidis,
leads to significant morbidity and mortality worldwide. This review aimed to establish the …

Neisseria meningitidis is a gram-negative diplococcus, for which humans are the only
reservoir. While colonization is common, invasive meningococcal disease in the form of …

Abstract The Global Meningococcal Initiative (GMI) is a global expert group, including
scientists, clinicians and public health officials from a wide range of specialities. The goal of …

The epidemiology of invasive meningococcal disease continues to change rapidly, even in
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …

Background A novel meningococcal serogroup A conjugate vaccine (MACV [MenAfriVac])
was developed as part of efforts to prevent frequent meningitis outbreaks in the African …